Geranylacetone

CAS No. 3796-70-1

Geranylacetone( —— )

Catalog No. M21257 CAS No. 3796-70-1

Geranylacetone has trypanostatic activity and could protect animals against the T. congolense-induced anaemia through the inhibition of sialidase and/or the protection of the parasite-induced hepatosplenomegaly.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
100MG 47 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Geranylacetone
  • Note
    Research use only, not for human use.
  • Brief Description
    Geranylacetone has trypanostatic activity and could protect animals against the T. congolense-induced anaemia through the inhibition of sialidase and/or the protection of the parasite-induced hepatosplenomegaly.
  • Description
    Geranylacetone has trypanostatic activity and could protect animals against the T. congolense-induced anaemia through the inhibition of sialidase and/or the protection of the parasite-induced hepatosplenomegaly.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3796-70-1
  • Formula Weight
    194.31
  • Molecular Formula
    C13H22O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(=O)CC\C=C(/C)CC\C=C(\C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Saad Bello Saad et al. Trypanostatic activity of geranylacetone: mitigation of Trypanosoma congolense-associated pathological pertubations and insight into the mechanism of anaemia amelioration using in vitro and in silico models.[J]. Experimental parasitology 2019.
molnova catalog
related products
  • Atracurium besylate

    Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.

  • N-Formylcytisine

    N-Formylcytisine is a natural product isolated from the stem bark of Maackia amurensis.

  • LDC195943(IMT1)

    Anticancer.